These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 36528504)
1. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure. Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504 [TBL] [Abstract][Full Text] [Related]
2. COVID-19, vaccines and deficiency of ACE Angeli F; Reboldi G; Trapasso M; Zappa M; Spanevello A; Verdecchia P Eur J Intern Med; 2022 Sep; 103():23-28. PubMed ID: 35753869 [TBL] [Abstract][Full Text] [Related]
3. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System. Sansoè G; Aragno M J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705 [TBL] [Abstract][Full Text] [Related]
4. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
5. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19. Sackin H Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987 [TBL] [Abstract][Full Text] [Related]
6. Two hits to the renin-angiotensin system may play a key role in severe COVID-19. Tseng YH; Yang RC; Lu TS Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292 [TBL] [Abstract][Full Text] [Related]
7. Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection. Devaux CA; Camoin-Jau L Viruses; 2023 Apr; 15(5):. PubMed ID: 37243131 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS. Zorad S; Skrabanova M; Zilkova M; Cente M; Turic Csokova N; Kovacech B; Cizkova D; Filipcik P Physiol Res; 2024 Mar; 73(1):27-35. PubMed ID: 38466002 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
11. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Verdecchia P; Cavallini C; Spanevello A; Angeli F Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612 [TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
13. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection. Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758 [TBL] [Abstract][Full Text] [Related]
14. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection. Sinha A; Vaggu RG; Swain R; Patnaik S Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165 [TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Sparks MA; South AM; Badley AD; Baker-Smith CM; Batlle D; Bozkurt B; Cattaneo R; Crowley SD; Dell'Italia LJ; Ford AL; Griendling K; Gurley SB; Kasner SE; Murray JA; Nath KA; Pfeffer MA; Rangaswami J; Taylor WR; Garovic VD Hypertension; 2020 Nov; 76(5):1350-1367. PubMed ID: 32981369 [TBL] [Abstract][Full Text] [Related]
16. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week. Brojakowska A; Narula J; Shimony R; Bander J J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401 [TBL] [Abstract][Full Text] [Related]
18. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment. Chappell MC Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353 [TBL] [Abstract][Full Text] [Related]
19. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2. Ahmadi S; Khaledi S Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318 [TBL] [Abstract][Full Text] [Related]
20. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Hu Y; Liu L; Lu X Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]